. Author manuscript; available in PMC: 2015 Jun 1.

Published in final edited form as: J Clin Virol. 2014 Mar 13;60(2):127–132. doi: 10.1016/j.jcv.2014.03.002

Table 2. Antiretroviral therapy use and frequency of HHV-8 detected by PCR of oropharyngeal swabs.

Antiretroviral use	Subjects (n)	Sessions (n)	Proportion of swabs with HHV-8 detected (%)	Mean log₁₀ copies (SD)
ART-naïve	46	68	1231/ 3111 (39.6%)	4.9 (1.2)
Previous ART only	20	28	314/ 1272 (24.7%)	4.1 (1.0)
Non-HAART ART	9	12	228 / 661 (34.5%)	4.5 (1.1)
HAART, no PI	32	56	671 / 2216 (30.3%)	4.9 (1.2)
HAART with any PI	55	98	572 / 4348 (13.2%)	4.4 (1.1)
HAART with nelfinavir	12	21	217 / 1139 (19.1%)	4.9 (1.1)
Total	162	262	3,016 / 11,608 (26.0%)	4.7 (1.2)

Among sessions with ≥ 1 positive day

Abbreviations: HHV-8, human herpesvirus 8; ART, antiretroviral therapy; HAART, highly active ART; PI, protease inhibitor; SD, standard deviation